Anthony D'Adamio - 10 Apr 2025 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & General Counsel
Signature: /s/ Anthony D'Adamio
Issuer symbol: BVS
Transactions as of: 10 Apr 2025
Transactions value $: $0
Form type: 4
Date filed: 11 Apr 2025, 17:30
Previous filing: 18 Mar 2025
Next filing: 15 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+9.93K	+7.98%	$0.00	134K	10 Apr 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-9.93K	-33.33%	$0.00	19.9K	10 Apr 2025	Class A Common Stock	9.93K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.